SAN FRANCISCO, Oct. 29 – Xanthon will partner with Duke University and University of North Carolina at Chapel Hill scientists in a two-year oligonucleotide array project that received funding from the North Carolina Biotechnology Center, the company announced Monday.

The project is called “Fabrication and Interrogation of Ultradense Oligonucleotide Arrays.” Xanthon will commercialize resulting technology, the company said.

Grant amount and details of the agreement between Xanthon and the universities were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.